Congestive heart failure (CHF) encompasses a spectrum of clinical syndromes and presentations. It affects 1-2% of the population in the UK and is associated with significant mortality which is comparable to most cancers. It accounts for more than 5% of adult medical admissions in the UK, with...

In view of sweeping health and human service reforms around the US and abroad, program performance standards, their measurement, and their application in program accountability have become critical functions. Measuring the performance of healthcare systems has added a new dimension to the...

This article evaluates the cost effectiveness of and patients' willingness to pay for interventions by community pharmacists in the overall context of pharmaceutical care. The rationale for interventions by pharmacists in patient care is examined from the viewpoint of clinical and economic needs...

Multidisciplinary team disease management has evolved into consensus `best practice' in the care of patients with chronic heart failure (CHF). The mission of disease management for patients with CHF is to shift care from the hospital to the clinic and to the home, optimize quality of care in...

There is a growing interest in the US among payors, purchasers of healthcare benefits, providers, policy-makers and the public in the promise of disease management or disease-specific care. While there have been early efforts to standardize the application and measurement of disease-specific...

Migraine is a common neurological disorder that remains under-recognized, under-diagnosed and under-treated. The disorder imposes a large burden on individuals and the wider community in terms of migraine-related disability and high healthcare and societal costs. Moreover, there is a discrepancy...

In this article, we review the reduction in healthcare costs associated with a health maintenance organization (HMO)-sponsored diabetes disease management program in Pennsylvania, USA. The program emphasizes primary care-based nurse education and case management of patients with diabetes...

The rapid expansion of disease management continues. A multitude of stakeholders and marketplaces are now involved in providing cost-effective quality healthcare for individuals and populations. To help you keep up-to-date with the very latest developments in disease management, this section of...

Disease management programs have been implemented into the German healthcare system. According to recent legislation they must include structured treatment and teaching programs for patients with diabetes mellitus and/or hypertension. This paper provides an overview of the current situation in...

The rapid expansion of disease management continues. A multitude of stakeholders and marketplaces are now involved in providing cost-effective quality healthcare for individuals and populations. To help you keep up-to-date with the very latest developments in disease management, this section of...